HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pioglitazone in patients with insulin resistance after ischemic stroke or transient ischemic attack: A comment on the IRIS trial.

AuthorsNiki Katsiki, Dimitri P Mikhailidis
JournalJournal of diabetes and its complications (J Diabetes Complications) Vol. 31 Issue 1 Pg. 1-3 (01 2017) ISSN: 1873-460X [Electronic] United States
PMID28340963 (Publication Type: Editorial, Comment)
Chemical References
  • Pioglitazone
Topics
  • Brain Ischemia
  • Humans
  • Insulin Resistance
  • Ischemic Attack, Transient
  • Pioglitazone
  • Stroke

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: